Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281738585> ?p ?o ?g. }
- W4281738585 abstract "The KMT2A (MLL) gene rearrangements (KMT2A-r) are associated with a diverse spectrum of acute leukemias. Although most KMT2A-r are restricted to nine partner genes, we have recently revealed that KMT2A-USP2 fusions are often missed during FISH screening of these genetic alterations. Therefore, complementary methods are important for appropriate detection of any KMT2A-r. Here we use a machine learning model to unravel the most appropriate markers for prediction of KMT2A-r in various types of acute leukemia. A Random Forest and LightGBM classifier was trained to predict KMT2A-r in patients with acute leukemia. Our results revealed a set of 20 genes capable of accurately estimating KMT2A-r. The SKIDA1 (AUC: 0.839; CI: 0.799-0.879) and LAMP5 (AUC: 0.746; CI: 0.685-0.806) overexpression were the better markers associated with KMT2A-r compared to CSPG4 (also named NG2; AUC: 0.722; CI: 0.659-0.784), regardless of the type of acute leukemia. Of importance, high expression levels of LAMP5 estimated the occurrence of all KMT2A-USP2 fusions. Also, we performed drug sensitivity analysis using IC50 data from 345 drugs available in the GDSC database to identify which ones could be used to treat KMT2A-r leukemia. We observed that KMT2A-r cell lines were more sensitive to 5-Fluorouracil (5FU), Gemcitabine (both antimetabolite chemotherapy drugs), WHI-P97 (JAK-3 inhibitor), Foretinib (MET/VEGFR inhibitor), SNX-2112 (Hsp90 inhibitor), AZD6482 (PI3Kβ inhibitor), KU-60019 (ATM kinase inhibitor), and Pevonedistat (NEDD8-activating enzyme (NAE) inhibitor). Moreover, IC50 data from analyses of ex-vivo drug sensitivity to small-molecule inhibitors reveals that Foretinib is a promising drug option for AML patients carrying FLT3 activating mutations. Thus, we provide novel and accurate options for the diagnostic screening and therapy of KMT2A-r leukemia, regardless of leukemia subtype." @default.
- W4281738585 created "2022-06-13" @default.
- W4281738585 creator A5005361536 @default.
- W4281738585 creator A5006792460 @default.
- W4281738585 creator A5009969425 @default.
- W4281738585 creator A5023677984 @default.
- W4281738585 creator A5033302876 @default.
- W4281738585 creator A5053681765 @default.
- W4281738585 creator A5061934865 @default.
- W4281738585 creator A5086985283 @default.
- W4281738585 creator A5089245995 @default.
- W4281738585 date "2022-06-06" @default.
- W4281738585 modified "2023-10-18" @default.
- W4281738585 title "Novel Diagnostic and Therapeutic Options for KMT2A-Rearranged Acute Leukemias" @default.
- W4281738585 cites W185699785 @default.
- W4281738585 cites W1974937620 @default.
- W4281738585 cites W1976892551 @default.
- W4281738585 cites W1986490316 @default.
- W4281738585 cites W1999574084 @default.
- W4281738585 cites W2006617902 @default.
- W4281738585 cites W2014291466 @default.
- W4281738585 cites W2032165298 @default.
- W4281738585 cites W2035132318 @default.
- W4281738585 cites W2037013605 @default.
- W4281738585 cites W2042229827 @default.
- W4281738585 cites W2045949302 @default.
- W4281738585 cites W2052568445 @default.
- W4281738585 cites W2061801397 @default.
- W4281738585 cites W2066106750 @default.
- W4281738585 cites W2098802923 @default.
- W4281738585 cites W2100905170 @default.
- W4281738585 cites W2108068107 @default.
- W4281738585 cites W2110502951 @default.
- W4281738585 cites W2114104545 @default.
- W4281738585 cites W2119831716 @default.
- W4281738585 cites W2130116522 @default.
- W4281738585 cites W2131271579 @default.
- W4281738585 cites W2145825942 @default.
- W4281738585 cites W2146512944 @default.
- W4281738585 cites W2146887040 @default.
- W4281738585 cites W2156665896 @default.
- W4281738585 cites W2169456326 @default.
- W4281738585 cites W2197774076 @default.
- W4281738585 cites W2230320310 @default.
- W4281738585 cites W2239688246 @default.
- W4281738585 cites W2322016289 @default.
- W4281738585 cites W2397945685 @default.
- W4281738585 cites W242040007 @default.
- W4281738585 cites W2532542358 @default.
- W4281738585 cites W2587240909 @default.
- W4281738585 cites W2733265822 @default.
- W4281738585 cites W2759969772 @default.
- W4281738585 cites W2766748732 @default.
- W4281738585 cites W2794175938 @default.
- W4281738585 cites W2796292093 @default.
- W4281738585 cites W2888181601 @default.
- W4281738585 cites W2891484660 @default.
- W4281738585 cites W2896480326 @default.
- W4281738585 cites W2898977037 @default.
- W4281738585 cites W2909089145 @default.
- W4281738585 cites W2916162780 @default.
- W4281738585 cites W2923057410 @default.
- W4281738585 cites W2925277230 @default.
- W4281738585 cites W2944727022 @default.
- W4281738585 cites W2946173685 @default.
- W4281738585 cites W2963414887 @default.
- W4281738585 cites W2981878588 @default.
- W4281738585 cites W3009454107 @default.
- W4281738585 cites W3009547772 @default.
- W4281738585 cites W3023065423 @default.
- W4281738585 cites W3034956673 @default.
- W4281738585 cites W3081303687 @default.
- W4281738585 cites W3107626709 @default.
- W4281738585 cites W3111879617 @default.
- W4281738585 cites W3157298191 @default.
- W4281738585 cites W3171440887 @default.
- W4281738585 cites W3184535842 @default.
- W4281738585 cites W3198984157 @default.
- W4281738585 cites W3215895867 @default.
- W4281738585 cites W4246697467 @default.
- W4281738585 cites W4253157445 @default.
- W4281738585 cites W4254687493 @default.
- W4281738585 doi "https://doi.org/10.3389/fphar.2022.749472" @default.
- W4281738585 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35734412" @default.
- W4281738585 hasPublicationYear "2022" @default.
- W4281738585 type Work @default.
- W4281738585 citedByCount "5" @default.
- W4281738585 countsByYear W42817385852023 @default.
- W4281738585 crossrefType "journal-article" @default.
- W4281738585 hasAuthorship W4281738585A5005361536 @default.
- W4281738585 hasAuthorship W4281738585A5006792460 @default.
- W4281738585 hasAuthorship W4281738585A5009969425 @default.
- W4281738585 hasAuthorship W4281738585A5023677984 @default.
- W4281738585 hasAuthorship W4281738585A5033302876 @default.
- W4281738585 hasAuthorship W4281738585A5053681765 @default.
- W4281738585 hasAuthorship W4281738585A5061934865 @default.
- W4281738585 hasAuthorship W4281738585A5086985283 @default.
- W4281738585 hasAuthorship W4281738585A5089245995 @default.
- W4281738585 hasBestOaLocation W42817385851 @default.
- W4281738585 hasConcept C126322002 @default.